{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:33:59Z","timestamp":1790760839557,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":7908,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1990,12]]},"abstract":"<jats:p>1. Twelve healthy male volunteers participated in four experimental occasions during each of which they were dosed with one of the following anti\u2010psychotic drugs: chlorpromazine (50 mg), haloperidol (3 mg), sulpiride (400 mg) and placebo. Drugs were allocated to subjects in a double\u2010blind, crossover fashion. 2. The subject's mood state, psychometric performance and electroencephalogram (EEG) were assessed pre\u2010dose, and at 2, 4, 6, 8, 24 and 48 h post\u2010dose. Mood states were assessed using 16 visual analogue scales and psychomotor performance was measured using the following tests: elapsed time estimation, tapping rate, choice reaction times, a rapid information processing task, flash fusion threshold, a manipulative motor task, digit span, body sway and tremor. 3. Chlorpromazine and haloperidol significantly reduced subjective ratings of \u2018alertness\u2019 and \u2018contentedness\u2019, and haloperidol significantly reduced feelings of \u2018calmness\u2019. Sulpiride did not significantly affect any of the visual analogue scales. 4. All three anti\u2010psychotic drugs had similar EEG effects with peak effect 2 to 4 h postdose. The profile was characterised by an increase in the proportion of slow wave activity (delta and theta) as well as decreased alpha (8\u201014 Hz) and faster (beta) wave activity. 5. Chlorpromazine reduced tapping rate and increased choice reaction movement times. Haloperidol reduced the flash fusion threshold frequency at 6 h post\u2010 dose. Sulpiride prolonged the duration of the manipulative motor task, particularly at 48 h post\u2010dose. 6. All three anti\u2010psychotic drugs impaired performance on the rapid information processing task. Chlorpromazine significantly reduced the number of correct letter pair identifications at 2, 4 and 6 h post\u2010dose, haloperidol at 4, 6, 8, 24 and 48 h post\u2010dose, and sulpiride at 24 h post\u2010dose.(ABSTRACT TRUNCATED AT 250 WORDS)<\/jats:p>","DOI":"10.1111\/j.1365-2125.1990.tb05444.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:41:59Z","timestamp":1343349719000},"page":"795-803","source":"Crossref","is-referenced-by-count":49,"title":["A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers."],"prefix":"10.1111","volume":"30","author":[{"given":"GR","family":"McClelland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ","family":"Pilgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1085","article-title":"Computer\u2010nystagmography, a new method of determining changes in vigilance as a response to psychotropic drugs.","volume":"24","author":"Aschoff von J. C.","year":"1974","journal-title":"Arzneim.-Forsch."},{"key":"e_1_2_1_3_1","volume-title":"The pharmacological basis of therapeutics","author":"Baldessarini R. J.","year":"1980"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8760(86)90045-0"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8325.1984.tb00164.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1967.tb02140.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1974.tb02285.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.09.040169.001325"},{"key":"e_1_2_1_9_1","first-page":"319","article-title":"Pharmacokinetic studies on haloperidol in man.","volume":"20","author":"Foreman A.","year":"1976","journal-title":"Curr. Ther. Res."},{"key":"e_1_2_1_10_1","first-page":"123P","article-title":"Measurement of body sway using ultrasound.","volume":"21","author":"Francis G. R.","year":"1986","journal-title":"Br. J. clin. Pharmac."},{"key":"e_1_2_1_11_1","volume-title":"Oxford textbook of psychiatry.","author":"Gelder M. G.","year":"1983"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/00335557043000041"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(83)90086-6"},{"key":"e_1_2_1_14_1","first-page":"117P","article-title":"Use of a visual analogue meter.","volume":"23","author":"Hounslow N. J.","year":"1987","journal-title":"Br. J. clin. Pharmac."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1975.tb00152.x"},{"key":"e_1_2_1_16_1","volume-title":"Electroencephalography in drug research","author":"Herrmann W. M.","year":"1982"},{"key":"e_1_2_1_17_1","first-page":"79","article-title":"Metabolism of sulpiride in man and Rhesus monkeys.","volume":"232","author":"Imondi A. R.","year":"1978","journal-title":"Arch. int. Pharmac."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(82)90184-5"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1094590"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1094332"},{"key":"e_1_2_1_21_1","first-page":"583","article-title":"Psychologische Untersuchungen nach Dogmatil\u2010Applikation.","volume":"116","author":"Lewrenz H.","year":"1974","journal-title":"M\u00fcnch. med. Wschr."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470020206"},{"key":"e_1_2_1_23_1","first-page":"124P","article-title":"A microcomputer based system for the acquisition and analysis of electroencephalographic (EEG) data.","volume":"23","author":"McClelland G. R.","year":"1987","journal-title":"Br. J. clin. Pharmac."},{"key":"e_1_2_1_24_1","first-page":"202P","article-title":"Use of microprocessor technology in a test battery for psychopharmacological volunteer studies.","volume":"84","author":"McClelland G. R.","year":"1985","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_25_1","first-page":"268P","article-title":"Paroxetine and haloperidol: effects on psychomotor performance.","volume":"24","author":"McClelland G. R.","year":"1987","journal-title":"Br. J. clin. Pharmac."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00413239"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(71)90039-6"},{"key":"e_1_2_1_28_1","first-page":"562","article-title":"Haloperidol and chlorpromazine \u2014 comparative effects on arousal and performance.","volume":"3","author":"Parrott A. C.","year":"1975","journal-title":"IRCS med. Sci."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.158.3797.137"},{"key":"e_1_2_1_30_1","first-page":"489","article-title":"Determinations of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco\u2010EEG and psychometric studies \u2014 Part I.","volume":"21","author":"Saletu B.","year":"1983","journal-title":"Int. J. clin. Pharmac. Ther. Tox."},{"key":"e_1_2_1_31_1","first-page":"544","article-title":"Determination of the pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco\u2010EEG, and psychometric studies. Part II.","volume":"21","author":"Saletu B.","year":"1983","journal-title":"Int. J. clin. Pharmac. Ther. Tox."},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429268"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1963.01720130076008"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431753"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558453"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1990.tb05444.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1990.tb05444.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T18:13:39Z","timestamp":1697998419000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1990.tb05444.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["10.1111\/j.1365-2125.1990.tb05444.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1990.tb05444.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}